Evolent Health (EVH) Azione Prezzo
Evolent Health Prezzo
Negli ultimi 13 anni Evolent Health ha aumentato il fatturato del 51,7% all'anno, raggiungendo 1,88 miliardi USD. Per Evolent Health, il margine netto del -28,5% risulta in calo rispetto al -4,1% di alcuni anni fa. Il target di prezzo di consenso a 12 mesi per Evolent Health è 7,00 USD, circa il 41,4% sopra il prezzo attuale di mercato. Su 18 analisti, 14 valutano il titolo come acquisto — nel complesso un consenso Acquistare.
Evolent Health Prezzo delle azioni
Accedi a questi dati tramite l’API Eulerpool
100.000 richieste/mese gratis · nessuna carta di credito
Evolent Health Azione e analisi azionaria
Domande frequenti sull'azione Evolent Health
Evolent Health Inc operates under a value-based care business model. This means that the company focuses on improving patient outcomes while reducing healthcare costs. Evolent Health works closely with healthcare providers to transition from a fee-for-service payment system to a more accountable care approach. By aligning financial incentives with patient outcomes, Evolent Health helps providers deliver better-quality care at a lower cost. This business model seeks to drive innovation and efficiency in the healthcare industry while promoting a patient-centric approach. Evolent Health Inc is committed to transforming healthcare delivery through their value-based care model.
Evolent Health Inc is primarily active in the healthcare industry.
The main competitors of Evolent Health Inc in the market include industry leaders such as Cerner Corporation, Athenahealth, Inc., and Allscripts Healthcare Solutions, Inc.
Evolent Health Inc. is a leading healthcare technology and services provider. Founded in 2011, the company revolutionizes the delivery of care by partnering with health systems and physician organizations. Evolent Health's goal is to help these organizations transition to value-based care models, enhancing patient outcomes while controlling costs. With its innovative solutions and data-driven insights, the company enables healthcare providers to improve clinical and financial performance. Evolent Health Inc. has proven expertise in population health management and offers a comprehensive suite of services, including patient engagement, analytics, and revenue cycle management, making it a trusted partner in the healthcare industry.
Evolent Health Inc has achieved several significant milestones since its inception. The company successfully completed its initial public offering (IPO) in June 2015, marking a major achievement for its growth and expansion. Evolent Health Inc has also established strategic partnerships with numerous leading healthcare providers and organizations, further enhancing its position in the market. With a focus on value-based care and population health management, the company has been recognized for its innovative solutions in improving patient outcomes and reducing healthcare costs. Evolent Health Inc continues to drive industry progress through its commitment to delivering high-quality healthcare services.
Evolent Health Inc primarily operates in the United States. With headquarters in Arlington, Virginia, the company focuses on providing healthcare solutions across the nation. Evolent Health Inc has established a strong presence in several states, delivering value-based care to health systems, health plans, and physicians. Through its innovative population health management approach, Evolent Health Inc aims to improve healthcare outcomes and enhance the overall patient experience. With its extensive network and partnerships, the company continues to positively impact the healthcare industry within the United States.
Evolent Health Inc represents values of collaboration, innovation, and patient-centric care. The company's corporate philosophy revolves around transforming the health care industry by empowering physicians, improving outcomes, and reducing costs. Evolent Health Inc places a strong emphasis on technology-driven solutions and data analytics to optimize care delivery. With a focus on value-based care models, the company aims to drive positive change in the healthcare ecosystem. Evolent Health Inc's commitment to quality, accountability, and transparency positions them as a leading player in the industry, dedicated to improving the health and well-being of individuals and communities.
Gli analisti fissano attualmente un prezzo obiettivo medio di 5,83 USD per l’azione Evolent Health (mediana: 7,00 USD), pari a +17,8 % rispetto all’ultimo prezzo. Il consenso si basa su 18 giudizi di analisti.
18 analisti valutano attualmente l’azione Evolent Health: 14 raccomandano l’acquisto, 4 la tenuta e 0 la vendita. Per il 2026 gli analisti si aspettano per Evolent Health ricavi pari a 2,64 miliardi USD e un utile per azione di 0,17 USD.
Convertita al tasso di cambio attuale, l’azione Evolent Health quota 4,47 EUR (4,95 USD).
L’azione Evolent Health (EVH) è quotata su 4 borse, tra cui: NYSE (EVH), Frankfurt (9EH.F), München (9EH.MU), Düsseldorf (9EH.DU).
Evolent Health Inc is a leading American provider of health management and claims processing services. The company offers a comprehensive and integrated health management system tailored to the needs of healthcare organizations and their patients. Evolent Health has three business areas: health plan management, popular reference group management for hospitals and healthcare organizations, and population health solution research. The main products of Evolent Health include: 1. Health plan management: Evolent Health supports health plans in managing insurance benefits for their customers. The company offers automation applications to reduce manual administrative processes, effective approaches to cost reduction for customers, and improved quality of service delivery. 2. Reference group management for hospitals and healthcare organizations: Evolent Health offers comprehensive reference group management services to hospitals and healthcare organizations. The company supports the implementation of solutions to improve workflows and provides a particularly tailored range of services. 3. Population health solutions: Evolent Health operates in the areas of digital transformation, analytics, and workforce management, developing corresponding population health solutions. These solutions are tailored to the individual needs of individuals and groups and aim to improve health and well-being. Overall, Evolent Health uses modern technologies and advanced analytics and data management tools to create a holistic strategy for health systems and service providers. The company works closely with its clients and partner companies to develop customized solutions and implement goals in a timely and effective manner. Evolent Health emphasizes open and trusting collaboration. In summary, the business model of Evolent Health is very complex and innovative. The company specializes in efficient and cost-effective health plan administration, as well as population health solutions. Through its tailored solutions and dedicated collaboration with clients and partners, Evolent Health has established a leading role in the healthcare sector.
Il attesa fatturato di Evolent Health ammonta a 2,64 miliardi USD. Questo dato si basa sui dati finanziari attuali e riflette lo sviluppo commerciale dell'azienda.
Il attesa profitto di Evolent Health ammonta a 19,00 Mio. USD. L'utile netto riflette la redditività dell'azienda dopo la deduzione di tutti i costi.
Il rapporto prezzo/utili (P/E) di Evolent Health è attualmente 29,75. Il rapporto P/E confronta il prezzo attuale dell'azione con l'utile per azione e aiuta gli investitori a valutare la valutazione dell'azione Evolent Health.
Il rapporto prezzo/fatturato (P/S) di Evolent Health è attualmente 0,21. Il rapporto P/S confronta la capitalizzazione di mercato con il fatturato annuo e funge da indicatore di valutazione dell'azione Evolent Health.
Il Quality Score AlleAktien per Evolent Health è 5/10.
L'ISIN di Evolent Health è US30050B1017. L'ISIN (International Securities Identification Number) è un codice identificativo univoco a livello mondiale per i titoli.
Il WKN di Evolent Health è A14UCN. Il WKN (Wertpapierkennnummer) è un codice identificativo tedesco a sei cifre per i titoli.
Il ticker di Evolent Health è EVH. Con questo simbolo di borsa vengono negoziate le azioni Evolent Health in borsa.
Azione Evolent Health
Gruppo di pari di Evolent Health
Evolent Health Ticker
Evolent Health FIGI
Altre metriche e analisi di Evolent Health in Deep Dive.
La nostra analisi azionaria dell'azione Evolent Health include importanti indicatori finanziari come il fatturato, l'utile, il P/E, il P/S, l'EBIT, oltre a informazioni sul dividendo. Inoltre, esaminiamo aspetti come le azioni, la capitalizzazione di mercato, il debito, il patrimonio netto e le passività di Evolent Health. Se state cercando informazioni più dettagliate su questi temi, sulle nostre sottopagine offriamo analisi approfondite: